Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review

References

• International Diabetes Federation (IDF)IDF Diabetes Atlas7th ed2015 Available from: http://www.diabetesatlas.org/Accessed September 21, 2016
   Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2016Diabetes Care201639Suppl 1S1S11926696671
   PubMed Web of Science ®Google Scholar
• BaxterMHudsonRMahonJEstimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications, and the associated financial benefitDiabet Med201633111575158126773733
   PubMed Web of Science ®Google Scholar
• García-PérezLEAlvarezMDillaTGil-GuillénVOrozco-BeltránDAdherence to therapies in patients with type 2 diabetesDiabetes Ther20134217519423990497
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• KrassISchiebackPDhippayomTAdherence to diabetes medication: a systematic reviewDiabet Med201532672573725440507
   PubMed Web of Science ®Google Scholar
• IglayKCartierSERosenVMMeta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetesCurr Med Res Opin20153171283129626023805
   PubMed Web of Science ®Google Scholar
• BaserOTangiralaKWeiWXieLReal-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugsClinicoecon Outcomes Res2013549750524124384
   PubMedGoogle Scholar
• WangLWeiWMiaoRXieLBaserOReal-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database studyBMJ Open201334e002348
   PubMed Web of Science ®Google Scholar
• ChandranABonafedeMKNigamSSaltiel-BerzinRHirschLJLahueBJAdherence to insulin pen therapy is associated with reduction in healthcare costs among patients with type 2 diabetes mellitusAm Health Drug Benefits201583148158
   PubMed Web of Science ®Google Scholar
• WeiWPanCXieLBaserOReal-world insulin treatment persistence among patients with type 2 diabetesEndocr Pract2014201526124013990
   PubMed Web of Science ®Google Scholar
• EgedeLEGebregziabherMDismukeCEMedication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvementDiabetes Care201235122533253922912429
   PubMed Web of Science ®Google Scholar
• AndertenHDippelFWKostevKEarly discontinuation and related treatment costs after initiation of Basal insulin in type 2 diabetes patients: a German primary care database analysisJ Diabetes Sci Technol20159364465025573957
   PubMedGoogle Scholar
• HongJSKangHCRelationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South KoreaMed Care201149437838421368684
   PubMed Web of Science ®Google Scholar
• KleinmanNLSchanemanJLLynchWDThe association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetesJ Occup Environ Med200850121386139319092494
   PubMed Web of Science ®Google Scholar
• StuartBCDaiMXuJLohFHS DoughertyJDoes good medication adherence really save payers money?Med Care201553651752325961659
   PubMed Web of Science ®Google Scholar
• Perez-NievesMKabulSDesaiUBasal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the USCurr Med Res Opin201632466968026703951
   PubMed Web of Science ®Google Scholar
• ChengSHChenCCTsengCHDoes medication adherence lead to lower healthcare expenses for patients with diabetes?Am J Manag Care201319866267024304214
   PubMed Web of Science ®Google Scholar
• HagenSEWrightDWFinchRTalamontiWJEdingtonDWImpact of compliance to oral hypoglycemic agents on short-term disability costs in an employer populationPopul Health Manag2014171354123869539
   PubMed Web of Science ®Google Scholar
• BuysmanEKLiuFHammerMLangerJImpact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort studyAdv Ther201532434135525832470
   PubMed Web of Science ®Google Scholar
• KarveSClevesMAHelmMHudsonTJWestDSMartinBCAn empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patientsMed Care200846111125113318953222
   PubMed Web of Science ®Google Scholar
• AyyagariRWeiWChengDPanCSignorovitchJWuEQEffect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatmentValue Health201518219820525773555
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHLageMJPerez-NievesMEarly discontinuation and restart of insulin in the treatment of type 2 diabetes mellitusDiabetes Ther20145122524224782063
   PubMed Web of Science ®Google Scholar
• HadjiyianniIDesaiUIvanovaJIBasal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in JapanValue Health2015187A611A612
   Web of Science ®Google Scholar
• CobdenDLeeWCBaluSJoshiAVPashosCLHealth outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitusPharmacotherapy200727794896217594200
   PubMed Web of Science ®Google Scholar
• EncinosaWEBernardDDorADoes prescription drug adherence reduce hospitalizations and costs? The case of diabetesAdv Health Econ Health Serv Res20102215117320575232
   PubMedGoogle Scholar
• GentilLVasiliadisHMPrévilleMBerbicheDAdherence to oral antihyperglycemic agents among older adults with mental disorders and its effect on health care costs, Quebec, Canada, 2005–2008Prev Chronic Dis201512E23026719900
   PubMed Web of Science ®Google Scholar
• HansenRAFarleyJFDroegeMMaciejewskiMLA retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the United States from 2003 to 2005Clin Ther20103271308131920678679
   PubMed Web of Science ®Google Scholar
• ShenolikarRABalkrishnanRCamachoFTWhitmireJTAndersonRTComparison of medication adherence and associated healthcare costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysisClin Ther20062881199120716982297
   PubMed Web of Science ®Google Scholar
• BreitscheidelLStamenitisSDippelFWSchöffskiOEconomic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: a review paperJ Med Econ201013181519947905
   PubMedGoogle Scholar
• SalasMHughesDZuluagaAVardevaKLebmeierMCosts of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literatureValue Health200912691592219402848
   PubMed Web of Science ®Google Scholar
• BanerjiMADunnJDImpact of glycemic control on healthcare resource utilization and costs of type 2 diabetes: current and future pharmacologic approaches to improving outcomesAm Health Drug Benefits20136738239224991370
   PubMedGoogle Scholar
• CapocciaKOdegardPSLetassyNMedication adherence with diabetes medication: a systematic review of the literatureDiabetes Educ2016421347126637240
   PubMed Web of Science ®Google Scholar
• JhaAKAubertREYaoJTeagardenJREpsteinRSGreater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annuallyHealth Aff (Millwood)20123181836184622869663
   PubMed Web of Science ®Google Scholar
• BoyeKSCurtisSLageMGarcia-PerezLEAssociations between adherence and outcomes among older, type 2 diabetes patients: evidence from a Medicare Supplemental databasePatient Prefer Adherence20161615731581
   Google Scholar
• ZulligLLGelladWFMoaddebJImproving diabetes medication adherence: successful, scalable interventionsPatient Prefer Adherence2015913914925670885
   PubMedGoogle Scholar
• ShahVNGargSKManaging diabetes in the digital ageClin Diabetes Endocrinol2015116
   PubMedGoogle Scholar
• DayerLHeldenbrandSAndersonPGubbinsPOMartinBCSmartphone medication adherence apps: potential benefits to patients and providersJ Am Pharm Assoc2013532172181
   Google Scholar
• VervloetMvan DijkLSanten-ReestmanJSMS reminders improve adherence to oral medication in type 2 diabetes patients who are real time electronically monitoredInt J Med Inform201281959460422652012
   PubMed Web of Science ®Google Scholar
• VervloetMLinnAJvan WeertJCMde BakkerDHBouvyMLvan DijkLThe effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literatureJ Am Med Inform Assoc201219569670422534082
   PubMed Web of Science ®Google Scholar
• IngersollKSCohenJThe impact of medication regimen factors on adherence to chronic treatment: a review of literatureJ Behav Med200831321322418202907
   PubMed Web of Science ®Google Scholar
• DonnanPTMacDonaldTMMorrisADAdherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort studyDiabet Med200219427928411942998
   PubMed Web of Science ®Google Scholar
• DonnellyLAMorrisADEvansJMDARTS/MEMO collaborationAdherence to insulin and its association with glycaemic control in patients with type 2 diabetesQJM2007100634535017504861
   PubMed Web of Science ®Google Scholar
• PeyrotMBarnettAHMeneghiniLFSchumm-DraegerPMFactors associated with injection omission/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy studyDiabetes Obes Metab201214121081108722726104
   PubMed Web of Science ®Google Scholar